top of page

Other Insights from FSI

Highlights Q1 2024

Advanced GI Market Strategic Planning
Life Science Tools Fundraising Support
Radiology Decision Support Tool Go-to-Market Strategy
Intraoperative Tumor Visualization Commercial Assessment
Biopharma Strategic Partnering Advisory
Clinical Trial Supplies and Logistics Landscape Analysis
Academic Medical Center 5-year Strategic Plan
Brain-Computer Interface Implant Go-to-Market Strategy
CRO Business Development Strategy
Stroke Aspiration Catheter Market Entry Planning
Enteral Feeding Technology Commercial Due Diligence

Cardiovascular Devices Review 2024

This report highlights company performance in select Cardiovascular (CV) device segments
• Revenue performance of key public companies, as well as M&A and investments: Abbott, Boston Scientific, Edwards Lifesciences, J&J, and Medtronic
• Overview of VC investments, M&A and IPOs for select segments of interest: Atrial fibrillation, mechanical circulatory support, cardiac monitoring, cardiac rhythm management (CRM), and transcatheter valves

Opportunities in Precision Medicine for Neuroscience 2024

This deep dive looks at investment trends in precision medicine, the rationale for multicomponent biomarkers for neurological disorders, and examines the potential impact of PM approaches for Alzheimer's disease.

bottom of page